Pulmonary FibrosisSymptoms, Doctors, Treatments, Advances & More
Learn About Pulmonary Fibrosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Interstitial Lung Disease (ILD) Program
Paul Wolters is a Pulmonary Medicine provider practicing medicine in San Francisco, California. Dr. Wolters is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant. Dr. Wolters is board certified in American Board Of Internal Med/Critical Care Med, Critical Care Medicine and American Board Of Internal Med/Pulmonary Disease, Pulmonary Disease. Dr. Wolters is currently accepting new patients.
University Of Rochester
Patricia Sime is a Pulmonary Medicine provider practicing medicine in Rochester, New York. Dr. Sime is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Pneumonia, and Acute Interstitial Pneumonia. Dr. Sime is currently accepting new patients.
UVA Health Culpeper Medical Center
Imre Noth is a Pulmonary Medicine provider practicing medicine in Culpeper, Virginia. Dr. Noth is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Acute Interstitial Pneumonia, Lung Transplant, and Gastrostomy. Dr. Noth is currently accepting new patients.
Summary: This study is open to people aged 40 years or older who have at least 1 family member with pulmonary fibrosis. Pulmonary fibrosis is a condition where lung tissue becomes scarred, making it harder to breathe. People can join if a lung scan shows early changes in the lung, called interstitial lung abnormalities, which may lead to lung scarring. People with family members who have pulmonary fibrosis...
Design: This is a Phase 2, randomized, double-blind, placebo-controlled, multi-center study that includes a 28-day Screening Period, a 24-week Treatment Period, and 4-week Follow-up Period. Study Assessments: Up to 9 visits to the study clinic will be required. Safety and tolerability will be evaluated with the following assessments: physical examination; collection of vital sign data (heart rate, blood p...